i-Stat BNP cartridges Abbott Point of Care Inc. The i-Stat BNP test is an in vitro diagnostic test for the quantitative measurement of B-type Natriuretic Peptide (BNP) in whole blood or plasma samples using EDTA as the anticoagulant. BNP measurements can be used as an aid in the diagnosis and assessment of the severity of congestive heart failure.
Published August 15, 2012 · Recall initiated: February 1, 2012
Summary
FDA records medical device Class II recall Z-2170-2012, published August 15, 2012 and initiated February 1, 2012. Recalling firm: Abbott Point Of Care Inc.; Status: Terminated; Reported quantity: 1,004,200 cartridges US; 54,200 cartridges OUS; Lot: List number 06F30-01, 06F30-02, 03P93-25, 600-9010-25 All lots. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
The frequency of suppressed results for i-Stat cTnl, BNP and CK-MP cartridges is affected by atmospheric pressure.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Abbott Point Of Care Inc.
- Distributor
- Worldwide Distribution - USA including AZ and CO and internationally to Argentina, Australia, Austria, Belgium, Bolivia, Brazil, Chile, China, Colombia, Costa Rica, Dominican Republic, El Salvador, Finland, France, Georgia, Germany, Greece, Honduras, Hong Kong, India, Ireland, Italy, Korea, Kuwait, Mauritius, Mexico, Netherland (Antilles), Nigeria, Norway, Oman, Paraguay, Peru, Poland, Portugal, Qatar, Russia, Saudi Arabia, Singapore, South Africa, Spain, Sweden, Switzerland, Taiwan, R.O.C., Thailand, UAE, United Kingdom, and Yemen.
- Lot
- List number 06F30-01, 06F30-02, 03P93-25, 600-9010-25 All lots
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAi-STAT EG6+ cartridge; List Number: 03P77-25;May 6, 2026
- FDAi-STAT G3+ cartridge; List Number: 03P78-26;May 6, 2026
- FDAi-STAT EG7+ cartridge; List Number: 03P76-25;May 6, 2026
- FDAi-STAT EG6+ cartridge. List Number: 03P77-25.September 24, 2025
- FDAi-Stat cTnl cartridges Abbott Point of Care Inc. The i-Stat cTnl test is an in vitro diagnostic test for theAugust 15, 2012
- FDAi-Stat CK-MP cartridges Abbott Point of Care Inc. The i-Stat CKMB test is an in vitro diagnostic test for theAugust 15, 2012
Questions about this recall
Was i-Stat BNP cartridges Abbott Point of Care Inc. The i-Stat BNP test is an in vitro diagnostic test for the quantitative measurement of B-type Natriuretic Peptide (BNP) in whole blood or plasma samples using EDTA as the anticoagulant. BNP measurements can be used as an aid in the diagnosis and assessment of the severity of congestive heart failure. recalled?
Yes. FDA published recall Z-2170-2012 on August 15, 2012. Reported hazard: The frequency of suppressed results for i-Stat cTnl, BNP and CK-MP cartridges is affected by atmospheric pressure.
What should I do if I have this product?
Voluntary: Firm initiated · Letter